Assessment of glucagon-like peptide-1 analogue and renin inhibitor on the binding and regulation of GLP-1 receptor in type 1 diabetic rat hearts.

Exp Diabetes Res · 2011 · PMC3124137 · PMID 21747829

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extremely significantno p-value reported

One can notice the extremely significant increase in K d constant in the diabetic untreated (D), treated with Exendin-4 (DE), treated with Aliskiren (DA), cotreated with Exendin-4 and Aliskiren (DEA), and cotreated with Insulin and Aliskiren (DIA) compared to the normal.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.